Contribution of Xpert^® MTB/RIF to pediatric TB diagnosis in Mozambique

Int J Tuberc Lung Dis. 2023 May 1;27(5):419-421. doi: 10.5588/ijtld.22.0479.

Authors

C M Mutemba¹, A Schindele², I Munyangaju³, N Ramanlal⁴, I Manhiça¹, B José¹, W C Buck⁵

Affiliations

¹ Mozambique Ministry of Health, National Tuberculosis Control Program, Maputo, Mozambique.
² University of Witten/Herdecke, Witten, Germany.
³ Elizabeth Glaser Pediatric AIDS Foundation, Maputo, Mozambique, Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
⁴ Ariel Glaser Foundation, Maputo, Mozambique.
⁵ University of California Los Angeles, David Geffen School of Medicine, Los Angeles, CA, USA.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antibiotics, Antitubercular* / therapeutic use
Child
Humans
Mozambique / epidemiology
Mycobacterium tuberculosis*
Rifampin
Sensitivity and Specificity
Tuberculosis, Pulmonary* / diagnosis

Substances

Rifampin
Antibiotics, Antitubercular